[ Price : $8.95]
FDA plans to finalize by 9/30 its draft guidance entitled Cybersecurity in Medical Devices: Quality System Considerations and Cont...[ Price : $8.95]
Regeneron Pharmaceuticals wins FDA approval for high-dose Eylea HD (aflibercept) injection 8 mg after resolving inspection concern...[ Price : $8.95]
HHS secretary Xavier Becerra announces that FDA commissioner Robert Califf will be heading soon to India to meet with Indian regul...[ Price : $8.95]
Federal Register notice: FDA determines that Accord Healthcares bortezomib solution was not withdrawn due to safety or effectivene...[ Price : $8.95]
Federal Register notice: FDA denies a request for a hearing and permanently debars David Roy Winne from providing services related...[ Price : $8.95]
FDA clears an Anika Therapeutics 510(k) for the Integrity Implant System, intended for use in augmenting an injured tendon to prom...[ Price : $8.95]
FDA approves a Regeneron Pharmaceuticals BLA for Veopoz (pozelimab-bbfg) for treating adult and pediatric patients one year of age...[ Price : $8.95]
Merck says it will submit to FDA favorable data from its LITESPARK-005 Phase 3 trial evaluating Welireg (belzutifan) for treating ...